Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients

समान संसाधन

• Mycobacterium leprae-Specific Antibodies in Multibacillary Leprosy Patients Decrease During and After Treatment With Either the Regular 12 Doses Multidrug Therapy (MDT) or the Uniform 6 Doses MDT
  द्वारा: Hungria, Emerith M., और अन्य
  प्रकाशित: (2018)
• Clinical trial for uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): adverse effects approach
  द्वारा: Cruz, Rossilene Conceição da Silva, और अन्य
  प्रकाशित: (2018)
• Leprosy reactions: The predictive value of Mycobacterium leprae-specific serology evaluated in a Brazilian cohort of leprosy patients (U-MDT/CT-BR)
  द्वारा: Hungria, Emerith Mayra, और अन्य
  प्रकाशित: (2017)
• Description of Leprosy Classification at Baseline among Patients Enrolled at the Uniform Multidrug Therapy Clinical Trial for Leprosy Patients in Brazil
  द्वारा: Moura, Rodrigo Scaliante, और अन्य
  प्रकाशित: (2015)
• Can baseline ML Flow test results predict leprosy reactions? An investigation in a cohort of patients enrolled in the uniform multidrug therapy clinical trial for leprosy patients in Brazil
  द्वारा: Hungria, Emerith Mayra, और अन्य
  प्रकाशित: (2016)